Specific biomarkers of interest for endometrial cancer include estrogen receptor (ER), progesterone receptor (PR), DNA Polymerase Epsilon (<i>POLE</i>), mismatch repair proteins (MMR), and Human Epidermal growth factor Receptor-2 (HER2). This evidence concerns the gene ESR1 and endometrial cancer.